ClinicalTrials.Veeva

Menu

Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations (HEMATO-WAST)

C

Centre Hospitalier Universitaire de Nīmes

Status

Terminated

Conditions

Deep Vein Thrombosis (DVT)/Thrombophlebitis
Pulmonary Embolism and Thrombosis
Intimate Partner Violence

Study type

Observational

Funder types

Other

Identifiers

NCT06415968
NIMAO/2023-2/JCG-01

Details and patient eligibility

About

Intimate violence against individuals, which is particularly marked among women, is one of the most widespread human rights violations in the world.

The Women Abuse Screening Tool (WAST) self-questionnaire is a screening tool validated in French.

Our preliminary data describing the association between intimate violence against women and the first attack of unexplained venous thromboembolic disease, show a significant frequency of positive responses to the WAST among women attending a biological hematology consultation at the CHU de Nîmes, for reasons of hemostasis disorders (8% out of the first 200 cases).

The study authors wish to establish the prevalence of this situation among patients presenting to the CHU de Nîmes for hematological exploration and management. They hypothesize that the prevalence of violence against individuals seen in Hematology consultations is higher among individuals with hemostasis pathologies (hemorrhagic and thrombotic pathologies) than those with cellular pathologies, and higher among women than men.

Enrollment

138 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Currently in a relationship or has been in one in the last 12 months, regardless of the length of the relationship

  • Willing to complete the anonymous WAST self-questionnaire

  • able to read and understand French

  • Outpatient consultant at Nîmes University Hospital in one of the following departments:

    • Biological hematology consultation
    • Clinical hematology consultation
    • Vascular medicine consultation

Exclusion criteria

  • Individuals under court protection, guardianship or curatorship
  • Individuals unable to read and understand French
  • Individuals who have already completed the WAST questionnaire during the study period
  • Individuals unable to get away from their partner during the consultation to complete the questionnaire in isolation

Trial design

138 participants in 1 patient group

Patients presenting at a biological hematology consultation

Trial contacts and locations

1

Loading...

Central trial contact

Jean-Christophe Gris

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems